Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Acazicolcept 💬[1] Acazicolcept (Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways)[1] Acazicolcept[2] CD28,
ICOS 💬
[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis 💬[1] 49 💬
2 Globulin, immune 💬
(Human normal immunoglobulin)
[1] Human immunoglobulin G (Human normal immunoglobulin)[7] Human Immunoglobulin; Human immunoglobulin G; HUMAN NORMAL IMMUNOGLOBULIN; Immune globulin; Immunoglobulin; IMMUNOGLOBULIN G; Intravenous Immunoglobulin--[4] 14, 50, 63, 65 💬
3 Talquetamab 💬[1] Talquetamab (IMMUNOGLOBULIN G4)[1] Talquetamab[1] CD3E 💬 [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[2] 11, 28 💬